Merck (NYSE:MRK) Intraday Stock Chart Today : Sunday 19 April 2015 By Peter Loftus Merck & Co.'s new cancer drug Keytruda improved the... ...http://in.advfn.com/p.php?pid=nmona&article=66477612
(Reuters) - Merck & Co Inc's Keytruda, approved for treating melanoma, was shown in a trial to shrink tumors in nearly half of advanced lung cancer... ...https://in.news.yahoo.com/mercks-keytruda-shrinks-lung-cancer-tumors-fda-approval-123506414--finance.html
By By | Reuters 7 minutes ago (Reuters) - Merck & Co Inc said on Sunday it has submitted an application to the U.S. Food and Drug Administration... ...https://in.news.yahoo.com/merck-files-fda-approval-keytruda-lung-cancer-120233920--finance.html
FRANKFURT (Reuters) - Germany's Merck ( MRCG.DE ) aims to quickly repay the up to $5 billion in bank loans it needed to fund the $17 billion... ...http://in.reuters.com/article/2015/04/18/us-merck-debt-idINKBN0N90J320150418
Comments ADELAIDE, Australia, April 17, 2015 /PRNewswire/ -- (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and... ...http://www.andhranews.net/Intl/Web/62-20.asp
We are one of the leading dealers,...
COMPLETE SOLUTION FOR BIOTECH RESEARCH